Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Current Assets (2016 - 2025)

Ptc Therapeutics has reported Current Assets over the past 14 years, most recently at $2.3 billion for Q4 2025.

  • Quarterly results put Current Assets at $2.3 billion for Q4 2025, up 66.52% from a year ago — trailing twelve months through Dec 2025 was $2.3 billion (up 66.52% YoY), and the annual figure for FY2025 was $2.3 billion, up 66.52%.
  • Current Assets for Q4 2025 was $2.3 billion at Ptc Therapeutics, up from $2.0 billion in the prior quarter.
  • Over the last five years, Current Assets for PTCT hit a ceiling of $2.3 billion in Q1 2025 and a floor of $517.3 million in Q3 2022.
  • Median Current Assets over the past 5 years was $1.1 billion (2021), compared with a mean of $1.2 billion.
  • Biggest five-year swings in Current Assets: plummeted 48.84% in 2022 and later soared 137.17% in 2024.
  • Ptc Therapeutics' Current Assets stood at $954.4 million in 2021, then fell by 27.3% to $693.8 million in 2022, then surged by 75.65% to $1.2 billion in 2023, then grew by 12.05% to $1.4 billion in 2024, then soared by 66.52% to $2.3 billion in 2025.
  • The last three reported values for Current Assets were $2.3 billion (Q4 2025), $2.0 billion (Q3 2025), and $2.3 billion (Q2 2025) per Business Quant data.